CJC-1295 GH IGF-1 axis means two hormone steps.

The growth gland acts first, and the liver acts next

The CJC-1295 GH IGF-1 axis is a two-step hormone change that starts at the small growth gland under your brain and continues in the liver after growth hormone travels through your blood. This page tells you where both hormones come from.

CJC-1295 reaches the growth gland under your brain. It attaches to the gland and starts growth hormone release ^[2].

Growth hormone then travels to the liver. The liver makes insulin-like growth factor 1, a second hormone that doctors call IGF-1 on blood tests.

Much of growth hormone's work comes from insulin-like growth factor 1. Lab papers trace the cell changes between the first hormone and the second.

Those cell changes don't tell us whether a person feels better. They explain how the liver gets the order to make more insulin-like growth factor 1.

The long form holds albumin, a blood protein. That hook keeps the message going while growth hormone still rises in waves ^[3].

CJC-1295 raised both blood hormones in healthy young men

One human test gave healthy young men a single shot. The amount was 60 or 90 micrograms for each kilogram of body weight.

A microgram is a millionth of a gram, and heavier men received more. Growth hormone rose about 7.5-fold, or seven and a half times its start.

After one week, the average growth hormone level was about 46% higher ^[3]. Insulin-like growth factor 1 was about 45% higher.

Their growth hormone still rose and fell. Another test used 30 or 60 micrograms for each kilogram of body weight.

Growth hormone stayed higher for at least six days ^[1]. Insulin-like growth factor 1 stayed higher from nine through eleven days.

In a test of 11 men, one fat-carrying protein and one thyroid-related form fell. Pieces of albumin and immune proteins rose with insulin-like growth factor 1 ^[5].

Those changes may confirm that both hormone steps are active. They don't tell us whether the men felt better.

A paper found one way insulin-like growth factor 1 may help muscle build protein ^[12]. It did not test CJC-1295 in people.

No human trial showed that insulin-like growth factor 1 meant better muscle, less fat, or faster healing. That's the line between blood and daily life.

CJC-1295 with a blood-protein hook stays for days

How long CJC-1295 stays depends on the form. The long form joins albumin and remains about 5.8–8.1 days ^[1].

After more than one shot, insulin-like growth factor 1 stayed high for up to 28 days. The short form, called Modified GRF 1-29, has no albumin hook.

That long lab name means a changed copy of a short body hormone. The short form acts for minutes or hours ^[1].

The form comparison keeps those times straight. You'll see why the two names can't be swapped.

CJC-1295 with ipamorelin, another lab drug, has no long trial

Ipamorelin is a lab-made drug that also tells the growth gland to act. It uses a different route inside the body than CJC-1295.

When related drug types were given together, the quick growth hormone rise was larger ^[10]. The study did not test the exact pair.

That short result is why people discuss the two drugs together. No long human test checked the pair.

Researchers haven't proved better weight, muscle, sleep, or aging. A quick rise in insulin-like growth factor 1 can't answer those questions.

CJC-1295 kept insulin-like growth factor 1 higher for days

CJC-1295 first raises growth hormone. The liver then makes insulin-like growth factor 1.

Single amounts of 30–60 micrograms for each kilogram raised insulin-like growth factor 1 by 1.5- to 3-fold. That means one and a half to three times the start.

The rise lasted from nine through eleven days ^[1]. After more than one shot, insulin-like growth factor 1 stayed high for 28 days.

Some blood proteins rose or fell with insulin-like growth factor 1 ^[5]. The changes did not prove that the men felt better.

Longer insulin-like growth factor 1 exposure raises safety questions. It isn't proof of harm, and the risk answers explain the gaps.

CJC-1295 blood changes don’t prove that people feel better

The tests found higher growth hormone and higher insulin-like growth factor 1 ^[3]. They also found that growth hormone kept its normal waves.

No long human test proved less fat, more muscle, or slower aging. For now, the human proof stops at blood tests.

A promised body change goes beyond those results. It isn't a finding from a fair human trial.

CJC-1295 and ipamorelin have no proven safe long-term amount

No human trial has set a safe amount for the pair. Amounts shared online aren't backed by a controlled human test.

The only published reason for joining the drug types is a quick hormone rise ^[10]. That result doesn't prove a safe long-term plan.

The amounts used in studies are facts from short tests. They aren't directions for you.

CJC-1295 and ipamorelin are discussed, not proven as a treatment

CJC-1295 copies one growth-gland message. Ipamorelin uses a different body route to reach the same gland.

In a short test, related drug types produced more growth hormone together than either did alone ^[10]. The exact pair wasn't tested.

Researchers discuss the pair because of that quick blood result. No fair human trial has proved a daily benefit or a treatment plan.